Annual SGA
$17.45 M
-$1.17 M-6.30%
December 31, 2024
Summary
- As of March 13, 2025, TARA annual SGA is $17.45 million, with the most recent change of -$1.17 million (-6.30%) on December 31, 2024.
- During the last 3 years, TARA annual SGA has fallen by -$8.95 million (-33.90%).
- TARA annual SGA is now -33.90% below its all-time high of $26.40 million, reached on December 31, 2021.
Performance
TARA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.81 M
+$553.00 K+12.98%
December 1, 2024
Summary
- As of March 13, 2025, TARA quarterly SGA is $4.81 million, with the most recent change of +$553.00 thousand (+12.98%) on December 1, 2024.
- Over the past year, TARA quarterly SGA has increased by +$153.00 thousand (+3.28%).
- TARA quarterly SGA is now -32.16% below its all-time high of $7.09 million, reached on March 31, 2020.
Performance
TARA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$909.66 M
-$44.60 M-5.16%
December 1, 2024
Summary
- As of March 13, 2025, TARA TTM SGA is -$909.66 million, with the most recent change of -$44.60 million (-5.16%) on December 1, 2024.
- Over the past year, TARA TTM SGA has dropped by -$928.29 million (-4984.35%).
- TARA TTM SGA is now -8391.20% below its all-time high of -$10.71 million.
Performance
TARA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TARA Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -6.3% | +3.3% | -4984.4% |
3 y3 years | -33.9% | +7.4% | -4896.0% |
5 y5 years | +341.6% | +7.4% | -4896.0% |
TARA Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -33.9% | at low | -22.6% | +17.3% | -192.5% | at low |
5 y | 5-year | -33.9% | +341.6% | -32.2% | +166.7% | -3771.7% | at low |
alltime | all time | -33.9% | +341.6% | -32.2% | +988.9% | -8391.2% | at low |
Protara Therapeutics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $17.45 M(-6.3%) | - | - |
Dec 2024 | - | $4.81 M(+13.0%) | $17.45 M(+0.9%) |
Sep 2024 | - | $4.26 M(-0.3%) | $17.30 M(-1.3%) |
Jun 2024 | - | $4.27 M(+4.2%) | $17.52 M(-3.4%) |
Mar 2024 | - | $4.10 M(-12.0%) | $18.14 M(-2.6%) |
Dec 2023 | $18.62 M(-10.2%) | $4.66 M(+4.0%) | $18.62 M(-1.8%) |
Sep 2023 | - | $4.48 M(-8.4%) | $18.97 M(-0.1%) |
Jun 2023 | - | $4.89 M(+6.6%) | $18.99 M(-3.7%) |
Mar 2023 | - | $4.59 M(-8.3%) | $19.72 M(-4.9%) |
Dec 2022 | $20.74 M | $5.00 M(+11.0%) | $20.74 M(-5.5%) |
Sep 2022 | - | $4.51 M(-19.8%) | $21.95 M(-9.2%) |
Jun 2022 | - | $5.62 M(+0.3%) | $24.18 M(-5.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $5.61 M(-9.9%) | $25.47 M(-3.5%) |
Dec 2021 | $26.40 M(+17.5%) | $6.22 M(-7.7%) | $26.40 M(+3.6%) |
Sep 2021 | - | $6.74 M(-2.4%) | $25.49 M(+6.1%) |
Jun 2021 | - | $6.91 M(+5.6%) | $24.02 M(+9.6%) |
Mar 2021 | - | $6.54 M(+23.3%) | $21.91 M(-2.5%) |
Dec 2020 | $22.46 M(+468.4%) | $5.30 M(+0.7%) | $22.46 M(+18.5%) |
Sep 2020 | - | $5.27 M(+9.8%) | $18.96 M(+26.8%) |
Jun 2020 | - | $4.80 M(-32.4%) | $14.95 M(+41.1%) |
Mar 2020 | - | $7.09 M(+293.2%) | $10.60 M(+202.6%) |
Dec 2019 | $3.95 M(-58.5%) | $1.80 M(+43.7%) | $3.50 M(+106.3%) |
Sep 2019 | - | $1.26 M(+184.0%) | $1.70 M(+284.0%) |
Jun 2019 | - | $442.00 K | $442.00 K |
Dec 2018 | $9.52 M | - | - |
FAQ
- What is Protara Therapeutics annual SGA?
- What is the all time high annual SGA for Protara Therapeutics?
- What is Protara Therapeutics annual SGA year-on-year change?
- What is Protara Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Protara Therapeutics?
- What is Protara Therapeutics quarterly SGA year-on-year change?
- What is Protara Therapeutics TTM SGA?
- What is the all time high TTM SGA for Protara Therapeutics?
- What is Protara Therapeutics TTM SGA year-on-year change?
What is Protara Therapeutics annual SGA?
The current annual SGA of TARA is $17.45 M
What is the all time high annual SGA for Protara Therapeutics?
Protara Therapeutics all-time high annual SGA is $26.40 M
What is Protara Therapeutics annual SGA year-on-year change?
Over the past year, TARA annual SGA has changed by -$1.17 M (-6.30%)
What is Protara Therapeutics quarterly SGA?
The current quarterly SGA of TARA is $4.81 M
What is the all time high quarterly SGA for Protara Therapeutics?
Protara Therapeutics all-time high quarterly SGA is $7.09 M
What is Protara Therapeutics quarterly SGA year-on-year change?
Over the past year, TARA quarterly SGA has changed by +$153.00 K (+3.28%)
What is Protara Therapeutics TTM SGA?
The current TTM SGA of TARA is -$909.66 M
What is the all time high TTM SGA for Protara Therapeutics?
Protara Therapeutics all-time high TTM SGA is -$10.71 M
What is Protara Therapeutics TTM SGA year-on-year change?
Over the past year, TARA TTM SGA has changed by -$928.29 M (-4984.35%)